Henrik Hasle

  1. 2020
  2. Department of Clinical Medicine - Department of Paediatrics (Organisational unit)

    Henrik Hasle (Member)

    13 Nov 2020

    Activity: Membership typesMembership in review committee

  3. 2019
  4. I-BFM-AML-SG biannual meeting

    Henrik Hasle (Organizer)

    7 Dec 2019

    Activity: Participating in or organising an event typesParticipation in or organisation of workshop, seminar or course

  5. Unique pattern of leukemia in Down syndrome. Disparities and Outcomes in Acute Leukemia.

    Henrik Hasle (Lecturer)

    4 Nov 2019

    Activity: Talk or presentation typesLecture and oral contribution

  6. Bedømmelse af PhD afhandling. (Event)

    Henrik Hasle (Member)

    18 Sep 2019

    Activity: Membership typesMembership in review committee

  7. Bedømmelse af PhD afhandling. (Event)

    Henrik Hasle (Member)

    3 Jul 2019

    Activity: Membership typesMembership in review committee

  8. I-BFM-AML-SG biannual meeting

    Henrik Hasle (Organizer)

    20 May 2019

    Activity: Participating in or organising an event typesParticipation in or organisation of workshop, seminar or course

  9. Overview of childhood AML. Paediatric Strategy Forum for Medicinal Product Development for AML in Children and Adolescents

    Henrik Hasle (Lecturer)

    11 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  10. Diagnostics and classification of patients with MDS and myeloproliferative disorders

    Henrik Hasle (Lecturer)

    6 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  11. Individualized treatment for patients with JMML

    Henrik Hasle (Lecturer)

    5 Apr 2019

    Activity: Talk or presentation typesLecture and oral contribution

  12. 2016
  13. Central nervous system involvement in childhood acute lymphoblastic leukemia

    Henrik Hasle (Participant)

    13 Dec 2016

    Activity: Other activity typesOther

  14. I-BFM SG The International BFM Study Group (External organisation)

    Henrik Hasle (Chairman)

    2016 → …

    Activity: Membership typesMembership in committee, council, board

  15. 2015
  16. Aarhus University (External organisation)

    Henrik Hasle (Member)

    30 Oct 2015

    Activity: Membership typesMembership in review committee

  17. Aarhus University (External organisation)

    Henrik Hasle (Member)

    22 Jun 2015

    Activity: Membership typesMembership in review committee

  18. 2013
  19. Mental late effect in childhood cancer survivors and their siblings.

    Henrik Hasle (Participant)

    1 Nov 2013

    Activity: Other activity typesOther

  20. The molecular heterogeneity of MML rearranged pediatric AML.

    Henrik Hasle (Participant)

    26 Jun 2013

    Activity: Other activity typesOther

  21. American Society of Hematology; ICM - ASH (External organisation)

    Henrik Hasle (Member)

    2013 → …

    Activity: Membership typesMembership in committee, council, board

  22. 2012
  23. Early detection of molecular relapse in pediatric AML.

    Henrik Hasle (Lecturer)

    7 Dec 2012

    Activity: Talk or presentation typesLecture and oral contribution

  24. Early detection of molecular relapse in AML and possible consequences.: Childhood Leukemia Symposium

    Henrik Hasle (Lecturer)

    23 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  25. International Standards for diagnostics in AML in 2012.: Childhood Leukemia Symposium

    Henrik Hasle (Lecturer)

    23 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  26. ALL case with a leukemoid reaction/MDS 16 months before ALL.

    Henrik Hasle (Lecturer)

    21 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  27. Pre-emptive treatment of relapsed in AML with azacitidine.

    Henrik Hasle (Lecturer)

    21 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  28. NOPHO-AML current status

    Henrik Hasle (Lecturer)

    18 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  29. Vidaza program in myeloid leukemia.

    Henrik Hasle (Lecturer)

    18 Apr 2012

    Activity: Talk or presentation typesLecture and oral contribution

  30. AML treatment and complications: 2nd vietnamese course in pediatric oncology.

    Henrik Hasle (Lecturer)

    9 Feb 2012

    Activity: Talk or presentation typesLecture and oral contribution

  31. Hyperleukocytosis-Tumor lysis syndrome: 2nd Vietnamese course in pediatric oncology.

    Henrik Hasle (Lecturer)

    9 Feb 2012

    Activity: Talk or presentation typesLecture and oral contribution

  32. European Society of Paediatric Oncology (SIOPE) (External organisation)

    Henrik Hasle (Member)

    2012 → …

    Activity: Membership typesMembership in board of company or public organisation

  33. 2011
  34. Venous and arterial thromboembolism in children and adolescents in Denmark 1994-2006.

    Henrik Hasle (Participant)

    11 Nov 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination

  35. The effects of a controlled family nurse directed intervention program for parents hospitalized with children undergoing allogenic haematopoietic stem cell transplantation.

    Henrik Hasle (Participant)

    8 Nov 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination

  36. AML hos børn

    Henrik Hasle (Lecturer)

    26 Oct 2011

    Activity: Talk or presentation typesLecture and oral contribution

  37. SCT in children with AML indications and results.

    Henrik Hasle (Lecturer)

    15 Oct 2011

    Activity: Talk or presentation typesLecture and oral contribution

  38. Diagnosis and management of children with MDS and JMML.

    Henrik Hasle (Lecturer)

    10 Jun 2011

    Activity: Talk or presentation typesLecture and oral contribution

  39. NOPHO AML teatment and outcome.

    Henrik Hasle (Lecturer)

    14 Apr 2011

    Activity: Talk or presentation typesLecture and oral contribution

  40. Advanced MDS in children.: Diagnosis and management.

    Henrik Hasle (Lecturer)

    26 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  41. JMML

    Henrik Hasle (Lecturer)

    25 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  42. Refractory cytopenia in children. Diagnosis and management.

    Henrik Hasle (Lecturer)

    24 Mar 2011

    Activity: Talk or presentation typesLecture and oral contribution

  43. Late effect of cancer at a young age.: Registrybased studies of the health of cancer patients and their offspring.

    Henrik Hasle (Participant)

    4 Mar 2011

    Activity: Other activity typesOther (prizes, external teaching and other activities) - External teaching and subject coordination

  44. 2010
  45. AML: New approaches in diagnostics - new targets for therapy.

    Henrik Hasle (Participant)

    5 Oct 2010

    Activity: Other activity typesOther

  46. Annual meeting of the international BFM study

    Henrik Hasle (Invited speaker)

    3 Oct 2010

    Activity: Talk or presentation typesLecture and oral contribution

  47. Annual meeting of the international BFM study group

    Henrik Hasle (Invited speaker)

    3 Oct 2010

    Activity: Talk or presentation typesLecture and oral contribution

  48. MRD in AML: Annual meeting of the International BFM study group.

    Henrik Hasle (Participant)

    3 Oct 2010

    Activity: Other activity typesOther

  49. 7th meeting of EBMT

    Henrik Hasle (Invited speaker)

    2 Jun 2010

    Activity: Talk or presentation typesLecture and oral contribution

  50. Controversies in indications

    Henrik Hasle (Advisor)

    2 Jun 2010

    Activity: Consultancy typesConsultancy

  51. Mumbai Haematology Group Annual Meeting

    Henrik Hasle (Invited speaker)

    7 Mar 2010

    Activity: Talk or presentation typesLecture and oral contribution

  52. Mumbai Haematology Group Annual Meeting

    Henrik Hasle (Invited speaker)

    7 Mar 2010

    Activity: Talk or presentation typesLecture and oral contribution

  53. NFCG meeting

    Henrik Hasle (Invited speaker)

    4 Feb 2010

    Activity: Talk or presentation typesLecture and oral contribution

  54. 2009
  55. U-kursus i hæmatologi/onkologi for pædiatere

    Henrik Hasle (Participant)

    10 Nov 2009 → …

    Activity: Participating in or organising an event typesParticipation in or organisation af a conference

  56. Curative therapy of childhood MDS and JMML. ESO - Euroconference on myelodysplastic syndromes.

    Henrik Hasle (Lecturer)

    24 Oct 2009

    Activity: Talk or presentation typesLecture and oral contribution

Previous 1 2 Next